Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients

ABSTRACT: Objective: To develop a multivariable clinical prediction model for the requirement of aggressive immunosuppression with cytostatics, based on simple clinical record data and lab tests. The model is defined in accordance with the result of the kidney biopsies. Methods: Retrospective study...

Full description

Autores:
Restrepo Escobar, Mauricio
Granda Carvajal, Paula Andrea
Jaimes Barragán, Fabian Alberto
Tipo de recurso:
Article of investigation
Fecha de publicación:
2019
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/29831
Acceso en línea:
https://hdl.handle.net/10495/29831
Palabra clave:
Lupus Eritematoso Sistémico
Lupus Erythematosus, Systemic
Técnicas de Apoyo para la Decisión
Decision Support Techniques
Modelos Logísticos
Logistic Models
Nefritis Lúpica
Lupus Nephritis
Análisis Multivariante
Multivariate Analysis
Inmunosupresión
Immunosuppression
Tolerancia Inmunológica
Immune Tolerance
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
id UDEA2_a68df417b91bf92d1f30ad8bc20b8d7d
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/29831
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
dc.title.alternative.spa.fl_str_mv Desarrollo y validación interna de un modelo de predicción para estimar la probabilidad de requerir inmunosupresión intensiva con citostáticos en pacientes con nefritis lúpica de novo
title Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
spellingShingle Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
Lupus Eritematoso Sistémico
Lupus Erythematosus, Systemic
Técnicas de Apoyo para la Decisión
Decision Support Techniques
Modelos Logísticos
Logistic Models
Nefritis Lúpica
Lupus Nephritis
Análisis Multivariante
Multivariate Analysis
Inmunosupresión
Immunosuppression
Tolerancia Inmunológica
Immune Tolerance
title_short Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
title_full Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
title_fullStr Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
title_full_unstemmed Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
title_sort Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
dc.creator.fl_str_mv Restrepo Escobar, Mauricio
Granda Carvajal, Paula Andrea
Jaimes Barragán, Fabian Alberto
dc.contributor.author.none.fl_str_mv Restrepo Escobar, Mauricio
Granda Carvajal, Paula Andrea
Jaimes Barragán, Fabian Alberto
dc.subject.decs.none.fl_str_mv Lupus Eritematoso Sistémico
Lupus Erythematosus, Systemic
Técnicas de Apoyo para la Decisión
Decision Support Techniques
Modelos Logísticos
Logistic Models
Nefritis Lúpica
Lupus Nephritis
Análisis Multivariante
Multivariate Analysis
Inmunosupresión
Immunosuppression
Tolerancia Inmunológica
Immune Tolerance
topic Lupus Eritematoso Sistémico
Lupus Erythematosus, Systemic
Técnicas de Apoyo para la Decisión
Decision Support Techniques
Modelos Logísticos
Logistic Models
Nefritis Lúpica
Lupus Nephritis
Análisis Multivariante
Multivariate Analysis
Inmunosupresión
Immunosuppression
Tolerancia Inmunológica
Immune Tolerance
description ABSTRACT: Objective: To develop a multivariable clinical prediction model for the requirement of aggressive immunosuppression with cytostatics, based on simple clinical record data and lab tests. The model is defined in accordance with the result of the kidney biopsies. Methods: Retrospective study conducted with data from patients 16 years and older, with SLE and nephritis with less than 6 months of evolution. An initial bivariate analysis was conducted to select the variables to be included in a multiple logistic regression model. Goodness of fit was evaluated using a Hosmer–Lemeshow test (H–L) and the discrimination capacity of the model by means of the area under the ROC (AUC) curve. Results Data from 242 patients was gathered; of these, 18.2% (n=44) did not need an addition of cytostatics according to the findings of their kidney biopsies. The variables included in the final model were 24-h proteinuria, diastolic blood pressure, creatinine, C3 complement and the interaction of hematuria with leukocyturia in urinary sediment. The model showed excellent discrimination (AUC=0.929; 95% CI=0.894–0.963) and adequate calibration (H–L, P=.959). Conclusion In recent-onset LN patients, the decision to use or not to use intensive immunosuppressive therapy could be performed based on our prediction model as an alternative to kidney biopsies.
publishDate 2019
dc.date.issued.none.fl_str_mv 2019
dc.date.accessioned.none.fl_str_mv 2022-07-22T15:29:14Z
dc.date.available.none.fl_str_mv 2022-07-22T15:29:14Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):27-33.
dc.identifier.issn.none.fl_str_mv 1699-258X
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/29831
dc.identifier.doi.none.fl_str_mv 10.1016/j.reuma.2017.05.010
dc.identifier.eissn.none.fl_str_mv 1885-1398
identifier_str_mv Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):27-33.
1699-258X
10.1016/j.reuma.2017.05.010
1885-1398
url https://hdl.handle.net/10495/29831
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Reumatol. Clín.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 7
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad Española de Reumatología
Colegio Mexicano de Reumatología
Elsevier
dc.publisher.group.spa.fl_str_mv Grupo Académico de Epidemiología Clínica
Grupo de Reumatología Universidad de Antioquia -GRUA-
dc.publisher.place.spa.fl_str_mv Barcelona, España
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/1/RestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/2/license_rdf
https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/3/license.txt
bitstream.checksum.fl_str_mv 7ac80f4e6dc90c9208ba5e2fb56b360f
1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173204486094848
spelling Restrepo Escobar, MauricioGranda Carvajal, Paula AndreaJaimes Barragán, Fabian Alberto2022-07-22T15:29:14Z2022-07-22T15:29:14Z2019Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):27-33.1699-258Xhttps://hdl.handle.net/10495/2983110.1016/j.reuma.2017.05.0101885-1398ABSTRACT: Objective: To develop a multivariable clinical prediction model for the requirement of aggressive immunosuppression with cytostatics, based on simple clinical record data and lab tests. The model is defined in accordance with the result of the kidney biopsies. Methods: Retrospective study conducted with data from patients 16 years and older, with SLE and nephritis with less than 6 months of evolution. An initial bivariate analysis was conducted to select the variables to be included in a multiple logistic regression model. Goodness of fit was evaluated using a Hosmer–Lemeshow test (H–L) and the discrimination capacity of the model by means of the area under the ROC (AUC) curve. Results Data from 242 patients was gathered; of these, 18.2% (n=44) did not need an addition of cytostatics according to the findings of their kidney biopsies. The variables included in the final model were 24-h proteinuria, diastolic blood pressure, creatinine, C3 complement and the interaction of hematuria with leukocyturia in urinary sediment. The model showed excellent discrimination (AUC=0.929; 95% CI=0.894–0.963) and adequate calibration (H–L, P=.959). Conclusion In recent-onset LN patients, the decision to use or not to use intensive immunosuppressive therapy could be performed based on our prediction model as an alternative to kidney biopsies.RESUMEN: Objetivo: Desarrollar un modelo multivariado de predicción clínica basado en datos sencillos de la historia clínica y de las pruebas de laboratorio de la necesidad de inmunosupresión intensiva con citostáticos, definida de acuerdo con el resultado de la biopsia renal, en pacientes con LES y nefritis de reciente inicio. Metodología: Se realizó un estudio retrospectivo en 2 hospitales de tercer nivel en el que se recolectó información de pacientes mayores de 16 anos ˜ con LES y nefritis de menos de 6 meses de evolución. Se realizó un análisis bivariado inicial para seleccionar las variables a incluir en un modelo de regresión logística múltiple. Se evaluó la bondad de ajuste por medio del estadístico de Hosmer–Lemeshow (H-L) y la capacidad de discriminación del modelo mediante área bajo la curva ROC (AUC). Resultados: Se recolectó información de 242 pacientes, de los cuales el 18,2% (n = 44) no necesitaba tratamiento intensivo con citostáticos de acuerdo con los hallazgos de la biopsia renal. Las variables incluidas en el modelo final fueron proteinuria en 24 h, presión arterial diástolica, creatinina, complemento C3 y la combinación de hematuria con leucocituria presentes en el análisis del sedimento urinario. El modelo mostró una excelente capacidad de discriminación (AUC = 0,929; IC del 95% = 0,894–0,963) y adecuada calibración (H-L = 0,959). Conclusión: En pacientes con NL de reciente inicio, la decisión de usar o no terapia inmunosupresora intensiva podría ser realizada sobre la base de nuestro modelo de predicción como una alternativa a la biopsia renal.COL0010959COL00071217application/pdfengSociedad Española de ReumatologíaColegio Mexicano de ReumatologíaElsevierGrupo Académico de Epidemiología ClínicaGrupo de Reumatología Universidad de Antioquia -GRUA-Barcelona, Españainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis PatientsDesarrollo y validación interna de un modelo de predicción para estimar la probabilidad de requerir inmunosupresión intensiva con citostáticos en pacientes con nefritis lúpica de novoLupus Eritematoso SistémicoLupus Erythematosus, SystemicTécnicas de Apoyo para la DecisiónDecision Support TechniquesModelos LogísticosLogistic ModelsNefritis LúpicaLupus NephritisAnálisis MultivarianteMultivariate AnalysisInmunosupresiónImmunosuppressionTolerancia InmunológicaImmune ToleranceReumatol. Clín.Reumatología Clínica2733151ORIGINALRestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdfRestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdfArtículo de investigaciónapplication/pdf323443https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/1/RestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdf7ac80f4e6dc90c9208ba5e2fb56b360fMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/2/license_rdf1646d1f6b96dbbbc38035efc9239ac9cMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/29831oai:bibliotecadigital.udea.edu.co:10495/298312022-07-22 10:29:15.013Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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